ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Veeva Systems commences NYSE listing

Share On Facebook
share on Linkedin
Print

Veeva Systems, a leading provider of industry cloud software solutions for the global life sciences industry, opened for trading today on the New York Stock Exchange (NYSE:VEEV) under the ticker symbol “VEEV” after its initial public offering. Veeva Systems opened at $38 after pricing 13,045,000 shares at $20 per share. Barclays is the Designated Market Maker for the company’s stock.

Founder and CEO Peter Gassner, accompanied by members of Veeva System’s leadership team, celebrated the company’s first day of trading on the NYSE by ringing The Opening Bell and visiting the trading floor to witness the stock opening.

“We’re delighted to welcome Veeva Systems to the NYSE’s community of innovative technology companies,” said Scott R. Cutler, Executive Vice President, Head of Global Listings, NYSE Euronext. “We congratulate Veeva Systems on its IPO and are proud to partner with the company as it embarks on its journey as a publicly-traded company.”

“Veeva has been a pioneer in the industry cloud software category, with applications specifically tailored to meet the needs of the global life sciences industry,” said Peter Gassner, Founder and CEO of Veeva Systems. “By focusing on building the best products and ensuring our customers are successful, we believe we can continue to lead the move to industry cloud.”

In a statement the company said that they were are “a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 170 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Founded in 2007, Veeva is headquartered in the San Francisco Bay Area, with offices in Philadelphia, Barcelona, Budapest, London, Paris, Beijing, Shanghai, Osaka, Tokyo, Sydney, and Singapore”.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Ltd. ADVFN Ltd does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com